Measurements of adiposity as predictive biomarkers for response to first-line bevacizumab-based chemotherapy in epithelial ovarian cancer (EOC)
| Autor: | Thai, T., Penaroza, S., Benbrook, D.M., Thavathiro, E., Ding, K., McMeekin, D.S., Moore, K.N. |
|---|---|
| Zdroj: | In Gynecologic Oncology June 2014 133 Supplement 1:171-171 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect